Ishares Biotechnology Etf Technical Analysis
| IBB Etf | USD 173.20 1.17 0.67% |
As of the 10th of February, IShares Biotechnology retains the Market Risk Adjusted Performance of 0.2397, downside deviation of 1.06, and Risk Adjusted Performance of 0.1164. IShares Biotechnology technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the entity's future prices.
IShares Biotechnology Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as IShares, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ISharesIShares Biotechnology's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.iShares Biotechnology ETF's market price often diverges from its book value, the accounting figure shown on IShares's balance sheet. Smart investors calculate IShares Biotechnology's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since IShares Biotechnology's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between IShares Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
IShares Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to IShares Biotechnology's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of IShares Biotechnology.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in IShares Biotechnology on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding iShares Biotechnology ETF or generate 0.0% return on investment in IShares Biotechnology over 90 days. IShares Biotechnology is related to or competes with IShares SP, IShares SP, IShares MSCI, IShares SP, IShares International, IShares Global, and IShares Global. The fund generally will invest at least 80 percent of its assets in the component securities of its index and in investm... More
IShares Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure IShares Biotechnology's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess iShares Biotechnology ETF upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.06 | |||
| Information Ratio | 0.0627 | |||
| Maximum Drawdown | 5.75 | |||
| Value At Risk | (1.68) | |||
| Potential Upside | 2.6 |
IShares Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for IShares Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as IShares Biotechnology's standard deviation. In reality, there are many statistical measures that can use IShares Biotechnology historical prices to predict the future IShares Biotechnology's volatility.| Risk Adjusted Performance | 0.1164 | |||
| Jensen Alpha | 0.1031 | |||
| Total Risk Alpha | 0.0285 | |||
| Sortino Ratio | 0.0747 | |||
| Treynor Ratio | 0.2297 |
IShares Biotechnology February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1164 | |||
| Market Risk Adjusted Performance | 0.2397 | |||
| Mean Deviation | 0.9896 | |||
| Semi Deviation | 0.8588 | |||
| Downside Deviation | 1.06 | |||
| Coefficient Of Variation | 711.34 | |||
| Standard Deviation | 1.26 | |||
| Variance | 1.59 | |||
| Information Ratio | 0.0627 | |||
| Jensen Alpha | 0.1031 | |||
| Total Risk Alpha | 0.0285 | |||
| Sortino Ratio | 0.0747 | |||
| Treynor Ratio | 0.2297 | |||
| Maximum Drawdown | 5.75 | |||
| Value At Risk | (1.68) | |||
| Potential Upside | 2.6 | |||
| Downside Variance | 1.12 | |||
| Semi Variance | 0.7375 | |||
| Expected Short fall | (1.15) | |||
| Skewness | 0.3662 | |||
| Kurtosis | 0.0116 |
iShares Biotechnology ETF Backtested Returns
At this point, IShares Biotechnology is very steady. iShares Biotechnology ETF holds Efficiency (Sharpe) Ratio of 0.0813, which attests that the entity had a 0.0813 % return per unit of risk over the last 3 months. We have found twenty-six technical indicators for iShares Biotechnology ETF, which you can use to evaluate the volatility of the entity. Please check out IShares Biotechnology's Downside Deviation of 1.06, market risk adjusted performance of 0.2397, and Risk Adjusted Performance of 0.1164 to validate if the risk estimate we provide is consistent with the expected return of 0.1%. The etf retains a Market Volatility (i.e., Beta) of 0.73, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, IShares Biotechnology's returns are expected to increase less than the market. However, during the bear market, the loss of holding IShares Biotechnology is expected to be smaller as well.
Auto-correlation | 0.28 |
Poor predictability
iShares Biotechnology ETF has poor predictability. Overlapping area represents the amount of predictability between IShares Biotechnology time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of iShares Biotechnology ETF price movement. The serial correlation of 0.28 indicates that nearly 28.0% of current IShares Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.28 | |
| Spearman Rank Test | 0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 6.8 |
IShares Biotechnology technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
iShares Biotechnology ETF Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for iShares Biotechnology ETF across different markets.
About IShares Biotechnology Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of iShares Biotechnology ETF on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of iShares Biotechnology ETF based on its technical analysis. In general, a bottom-up approach, as applied to this etf, focuses on iShares Biotechnology ETF price pattern first instead of the macroeconomic environment surrounding iShares Biotechnology ETF. By analyzing IShares Biotechnology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of IShares Biotechnology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to IShares Biotechnology specific price patterns or momentum indicators. Please read more on our technical analysis page.
IShares Biotechnology February 10, 2026 Technical Indicators
Most technical analysis of IShares help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for IShares from various momentum indicators to cycle indicators. When you analyze IShares charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1164 | |||
| Market Risk Adjusted Performance | 0.2397 | |||
| Mean Deviation | 0.9896 | |||
| Semi Deviation | 0.8588 | |||
| Downside Deviation | 1.06 | |||
| Coefficient Of Variation | 711.34 | |||
| Standard Deviation | 1.26 | |||
| Variance | 1.59 | |||
| Information Ratio | 0.0627 | |||
| Jensen Alpha | 0.1031 | |||
| Total Risk Alpha | 0.0285 | |||
| Sortino Ratio | 0.0747 | |||
| Treynor Ratio | 0.2297 | |||
| Maximum Drawdown | 5.75 | |||
| Value At Risk | (1.68) | |||
| Potential Upside | 2.6 | |||
| Downside Variance | 1.12 | |||
| Semi Variance | 0.7375 | |||
| Expected Short fall | (1.15) | |||
| Skewness | 0.3662 | |||
| Kurtosis | 0.0116 |
iShares Biotechnology ETF One Year Return
Based on the recorded statements, iShares Biotechnology ETF has an One Year Return of 24.8%. This is 308.57% higher than that of the iShares family and about the same as Health (which currently averages 24.315) category. The one year return for all United States etfs is notably lower than that of the firm.
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.IShares Biotechnology February 10, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as IShares stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | (Huge) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 173.20 | ||
| Day Typical Price | 173.20 | ||
| Price Action Indicator | (0.59) |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Biotechnology ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
iShares Biotechnology ETF's market price often diverges from its book value, the accounting figure shown on IShares's balance sheet. Smart investors calculate IShares Biotechnology's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since IShares Biotechnology's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between IShares Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.